Evaluation of the Modified Early Warning Scoring System

NCT05575531 | Completed

• 1 other identifier: KAEK/17.bI.02
• Study Type: interventional
• Target: 220
• Locations: 1 country
• Sites: 1

Brief Summary

In this study, it was aimed to determine the effect of HRU and HG on patient outcomes in the care process in surgical patients followed according to MEUSS. The sample of the study, which was conducted as a randomized-controlled clinical trial, consisted of 252 patients who underwent surgical intervention under general anesthesia in a university hospital between 29 July 2022 and 31 October 2022.

Conditions

Clinical Deterioration; Postoperative Complications; Nurse's Role

Keywords

Clinical deterioration; early warning score; nursing assessment; postoperative care; surgical nursing

Outcome Measures

Primary Outcomes (3)

• Effects of MEWSS and NGA use on complications and clinical status

  Length of stay in ASBU (minutes), complications developed in ASBU, intervention time to complications (minutes), and where it was transferred after ASBU (clinical or intensive care unit)

  From the first 5 minutes when the patient comes to the post-anesthesia care unit to the end of the second hour

• Effect of MEWSS and NGA use on vital signs and MEWS

  Heart rate (beats per minute), respiratory rate (respiratory rate / min.), systolic blood pressure (mmHg), temperature (centigrade degree -°C), level of consciousness (AVPU) and the score obtained from these measurements show MEWS.

  From the first 5 minutes when the patient comes to the post-anesthesia care unit to the end of the second hour

• Effect of MEWSS and NGA use on nursing interventions

  Nursing interventions include practices such as oxygen saturation, blood pressure, pulse, respiration, body temperature, alertness, pain monitoring by nurses, positioning and giving medication.

  From the first 5 minutes when the patient comes to the post-anesthesia care unit to the end of the second hour

Study Arms (2)

Experimental Group

EXPERIMENTAL

MEWSS and Nursing Guide Application will be used in the study group. MEWSS: The Modified Early Warning Score (MEWS) consists of a simple to use algorithm based on physiological parameters such as heart rate, respiratory rate, systolic blood pressure, temperature and level of consciousness. Nursing Guide Application (NGA): According to the follow-up carried out in this study: If the patient's MEWSS is 4 or below, a ten-minute follow-up was performed. If the MEWSS is five, then five-minute follow-up is passed, and if the score has not changed as a result of the follow-ups, five-minute follow-ups are continued. If the score decreased to four or less, ten-minute follow-up was started, if the score increased, five-minute follow-ups were continued, and the emergency team was informed and the patient was evaluated (the emergency team was informed about the study).

Other: MEWSS and Nursing Guide Application

Control Group

NO INTERVENTION

In the control group, the patients followed according to the Modified Early Warning Scoring System received routine care in the clinic.

Interventions

MEWSS and Nursing Guide Application OTHER

MEWSS and Nursing Guide application will be used for the patients in the experimental group. According to the Nursing Guide application, patients with MEWS above 4 will be monitored every 5 minutes, while those with a score below 4 will be monitored for 10 minutes. will be followed intermittently. Nursing interventions will be made in accordance with the problems experienced by patients with a score above 4.

Experimental Group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Having operated under general anesthesia
• transferred to the post-anesthesia care unit (ASBU) and then to the service/ICU followed for 2 hours,
• between 18-65 years old,
• who have not had an operation with general anesthesia in the last six months,
• no serious life-threatening complications developed during surgery,
• patients willing to participate in the study

You may not qualify if:

• data unavailable,
• complications during surgery,
• patients who did not undergo general anesthesia

Sponsors & Collaborators

• Kocaeli University: lead

Study Sites (1)

Kocaeli University Hospital

Kocaeli, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Clinical Deterioration; Postoperative Complications

Condition Hierarchy (Ancestors)

Disease Progression; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Selda MERT, Assist.Dr.

  Kocaeli University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assist. Prof. Dr.

Model Details: Randomized-controlled clinical trial

Study Record Dates

• First Submitted: October 6, 2022
• First Posted: October 12, 2022
• Study Start: July 29, 2022
• Primary Completion: October 31, 2022
• Study Completion: January 12, 2023
• Last Updated: October 10, 2023

Record last verified: 2023-03

Locations

TU (1)